Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Tratamentul tulburărilor obsesiv-compulsive.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AB08 FLUVOXAMINUM COMPR. FILM. 100 mg

FEVARIN(R) 100 100 mg SOLVAY PHARMACEUTICALS BV

FLUVOXAMINE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL

N06AB08 FLUVOXAMINUM COMPR. FILM. 50 mg

FEVARIN(R) 50 50 mg SOLVAY PHARMACEUTICALS BV

FLUVOXAMINE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL

________________________________________________________________________________

______________________________________________________________________________

| 136 |N06AX03| MIANSERINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX03 MIANSERINUM COMPR. FILM. 10 mg

MIANSERIN 10 10 mg REMEDICA LTD.
N06AX03 MIANSERINUM DRAJ. 10 mg

MIANSERIN 10 mg 10 mg TERAPIA SA

N06AX03 MIANSERINUM COMPR. FILM. 30 mg

MIANSERIN 30 30 mg REMEDICA LTD.

N06AX03 MIANSERINUM DRAJ. 30 mg

MIANSERIN 30 mg 30 mg TERAPIA SA

________________________________________________________________________________
______________________________________________________________________________

| 137 |N06AX11| MIRTAZAPINUM* | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul episoadelor depresive majore.